Generalized Anxiety Disorder Adjunct Study

PHASE3CompletedINTERVENTIONAL
Enrollment

409

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
AnxietyAnxiety DisordersAnxiety NeurosesAnxiety States
Interventions
DRUG

Placebo

oral

DRUG

quetiapine fumarate XR

oral

Trial Locations (53)

Unknown

Research Site, Birmingham

Research Site, Little Rock

Research Site, Beverly Hills

Research Site, Encino

Research Site, Fresno

Research Site, La Mesa

Research Site, Oceanside

Research Site, Redlands

Research Site, San Diego

Research Site, San Francisco

Research Site, Sherman Oaks

Research Site, Bradenton

Research Site, Dayton

Research Site, Hialeah

Research Site, Jacksonville

Research Site, Maitland

Research Site, Miami

Research Site, North Miami

Research Site, Orlando

Research Site, Tampa

Research Site, West Palm Beach

Research Site, Atlanta

Research Site, Columbus

Research Site, Chicago

Research Site, Lafayette

Research Site, Merrillville

Research Site, Terre Haute

Research Site, Prairie Village

Research Site, Owenboro

Research Site, New Orleans

Research Site, Rockville

Research Site, Boston

Research Site, Cherry Hill

Research Site, Clementon

Research Site, Brooklyn

Research Site, Cedarhurst

Research Site, Fresh Meadows

Research Site, New York

Research Site, Rochester

Research Site, Staten Island

Research Site, Toledo

Research Site, Oklahoma City

Research Site, Portland

Research Site, Salem

Research Site, Philadelphia

Research Site, Memphis

Research Site, Houston

Research Site, San Antonio

Research Site, Witchita Falls

Research Site, Richmond

Research Site, Bellevue

Research Site, Seattle

Research Site, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY